Comprehensive genomic analyses have demonstrated that KRAS, one of the three major RAS oncogenes, is frequently altered in multiple types of cancer, including colorectal cancer (CRC) (2), non-small cell lung cancer (NSCLC) (3), and pancreatic ductal adenocarcinoma (PDAC) (4). The gene discussed is KRAS; the disease is cancer.